Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123997912 | 12399791 | 2 | F | 20160624 | 20160524 | 20160709 | EXP | US-009507513-1605USA006949 | MERCK | 60.00 | YR | F | Y | 72.56000 | KG | 20160709 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123997912 | 12399791 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, QD | Y | 21995 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 123997912 | 12399791 | 2 | SS | PIOGLITAZONE. | PIOGLITAZONE | 1 | Oral | 30 MG, QD | Y | 0 | 30 | MG | TABLET | QD | |||||
| 123997912 | 12399791 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | QD | ||||||
| 123997912 | 12399791 | 4 | C | OXITRIPTAN | OXITRIPTAN | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 123997912 | 12399791 | 5 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 1500 MG DAILY | U | 0 | QD | ||||||||
| 123997912 | 12399791 | 6 | C | PRINIVIL | LISINOPRIL | 1 | Oral | 5 MG, BID | U | 0 | 5 | MG | TABLET | BID | |||||
| 123997912 | 12399791 | 7 | C | VICTOZA | LIRAGLUTIDE | 1 | 1.2 MG, QD | U | 0 | 1.2 | MG | INJECTION | QD | ||||||
| 123997912 | 12399791 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | ONE SPRAY EACH NOSTRIL, DAILY | U | 0 | 100 | UG | NASAL SPRAY, SUSPENSION | QD | |||||
| 123997912 | 12399791 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 123997912 | 12399791 | 10 | C | APP CHONDROITIN MSM COMPLEX | 2 | Oral | 1103 MG, QD | U | 0 | QD | |||||||||
| 123997912 | 12399791 | 11 | C | GLUCOSAMINE HYDROCHLORIDE | GLUCOSAMINE HYDROCHLORIDE | 1 | Oral | 1500 MG, QD | U | 0 | QD | ||||||||
| 123997912 | 12399791 | 12 | C | ELIQUIS | APIXABAN | 1 | 5 MG, BID | U | 0 | 5 | MG | BID | |||||||
| 123997912 | 12399791 | 13 | C | AMIODARONE HYDROCHLORIDE. | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 123997912 | 12399791 | 14 | C | AMIODARONE HYDROCHLORIDE. | AMIODARONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 123997912 | 12399791 | 15 | C | TYLENOL ARTHRITIS PAIN | ACETAMINOPHEN | 1 | Oral | 640 MG, BID | U | 0 | 640 | MG | BID | ||||||
| 123997912 | 12399791 | 16 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 | |||||||||||
| 123997912 | 12399791 | 17 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | Oral | 50 MG, BID | U | U | 0 | 50 | MG | BID | |||||
| 123997912 | 12399791 | 18 | C | UBIDECARENONE | UBIDECARENONE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 123997912 | 12399791 | 19 | C | NSI BOSWELLIA EXTRACT | 2 | Oral | DAILY | U | 0 | QD | |||||||||
| 123997912 | 12399791 | 20 | C | METAMUCIL | PLANTAGO SEED | 1 | Oral | 5.8 MG, QD | U | 0 | 5.8 | MG | QD | ||||||
| 123997912 | 12399791 | 21 | C | ONE-A-DAY WOMENS 50 PLUS ADVANTAGE | 2 | Oral | DAILY | U | 0 | QD | |||||||||
| 123997912 | 12399791 | 22 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 3.125 MG, BID | U | 0 | BID | ||||||||
| 123997912 | 12399791 | 23 | C | DIMETHYL SULFONE | DIMETHYL SULFONE | 1 | U | 0 | |||||||||||
| 123997912 | 12399791 | 24 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG, BID | U | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123997912 | 12399791 | 1 | Diabetes mellitus |
| 123997912 | 12399791 | 2 | Diabetes mellitus |
| 123997912 | 12399791 | 3 | Hyperlipidaemia |
| 123997912 | 12399791 | 6 | Hypertension |
| 123997912 | 12399791 | 7 | Diabetes mellitus |
| 123997912 | 12399791 | 8 | Hypersensitivity |
| 123997912 | 12399791 | 9 | Fibromyalgia |
| 123997912 | 12399791 | 12 | Cardiac disorder |
| 123997912 | 12399791 | 13 | Atrial fibrillation |
| 123997912 | 12399791 | 15 | Fibromyalgia |
| 123997912 | 12399791 | 16 | Cardiac disorder |
| 123997912 | 12399791 | 17 | Fibromyalgia |
| 123997912 | 12399791 | 20 | Constipation |
| 123997912 | 12399791 | 22 | Cardiac disorder |
| 123997912 | 12399791 | 24 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123997912 | 12399791 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123997912 | 12399791 | Arthralgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123997912 | 12399791 | 1 | 20070901 | 20140901 | 0 | |
| 123997912 | 12399791 | 2 | 20091101 | 20150522 | 0 |